Having invested $2.5 billion and made $5 billion worth of exits across two decades, ChrysCapital has emerged as one of the largest homegrown private equity firms in India. In April, the PE firm and its investors bought 10% stake in Mankind Pharma Ltd for $350 million. Managing partner Kunal Shroff spoke about how ChrysCapital clinched the Mankind Pharma deal at the last minute and investment opportunities that have opened up in the distressed space. Edited excerpts from an interview:
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in